News Release

ELMSFORD, N.Y.--(BUSINESS WIRE)--Feb. 5, 2007--BioScrip, Inc. (NASDAQ:BIOS), a comprehensive pharmaceutical care solutions company, has named Mr. Douglas Lee as its Vice President and Chief Information Officer, responsible for leading the Company's information technology function, defining and implementing BioScrip's strategic use of information technology, and ensuring that the technology investment is positioned to support BioScrip's growth and system.

Mr. Lee was previously employed at Option Care, Inc. where he had served as its Chief Information Officer. Prior to Option Care, Inc., Mr. Lee was Chief Information Officer and Partner for Technology Extension Consulting, Inc, a national consulting practice, which provided interim senior level IT management for organizations. Mr. Lee has also held management positions in information technology in the telecommunications and telecommunications software industries. Mr. Lee earned his Masters in Business Administration from Aurora University and Bachelor of Arts in Strategic Planning and Business Administration from Ripon College

"We are pleased to have Douglas Lee join our team at this critical time. Currently, BioScrip has been undertaking many steps to improve our corporate systems in order to both streamline and expand our capabilities," noted Mr. Richard H. Friedman, the Company's Chairman and Chief Executive Officer. "By utilizing Doug's expertise to direct our information technology efforts, BioScrip will be well positioned to build out the necessary infrastructure to support future growth."

About BioScrip, Inc.

BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: Specialty Medication Distribution and Clinical Management Services, both nationally and community-based, and Pharmacy Benefit Management Services. Our specialty medication distribution capabilities include condition-specific clinical management programs tailored to improve the care of individuals with complex health conditions such as HIV/AIDS, Cancer, Infusion IVIG, Hepatitis C, Rheumatoid Arthritis, Multiple Sclerosis, and Transplantation. Our complete pharmacy benefit management programs include customized benefit plan design, pharmacy network management and sophisticated reporting capabilities that deliver improved clinical and economic outcomes. In addition, we have 35 locations including community and infusion pharmacies in major metropolitan markets across the U.S., providing nationwide access and clinical management capabilities in a high-touch community-based environment.

Forward Looking Statements

This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, the Company's ability to continue improving the above identified trends and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

CONTACT: BioScrip, Inc.
Craig Allison, 914-460-1636 (NY direct line)
Investor Relations
callison@bioscrip.com

SOURCE: BioScrip, Inc.